Mabylon AG, a clinical-stage biotech company, is leading innovation in antibody-based treatments for severe allergies, inflammation, and neurological disorders. Our B-cell screening platform rapidly identifies natural human antibodies with high specificity and therapeutic potential. MY006, our first-in-class multispecific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.
Looking for a particular Mabylon AG employee's phone or email?
Mabylon AG Questions
The Mabylon AG annual revenue was $1 million in 2026.
Alcide Barberis is the CEO and Director of Mabylon AG.
19 people are employed at Mabylon AG.
Mabylon AG is based in Schlieren, Zurich.
The NAICS codes for Mabylon AG are [54, 541, 5417, 541713, 54171].
The SIC codes for Mabylon AG are [873, 87].
Top Mabylon AG Employees
-
Alcide Barberis
CEO and Director at Mabylon AG
Switzerland35 -
23
-
1
-
1
-
1
-
Danaëlle Capron
Scientist Antibody Discovery at Mabylon AG
Zürich, ZH, CH1 -
Nikole Z
Senior Scientist Neurobiology at Mabylon AG
Zürich, ZH, CH
Related Companies
